Abstract
Diosgenin, a steroidal saponin, is a natural product found in many plants. Diosgenin has a wide range of pharmacological activities, and has been used to treat cancer, nervous system diseases, inflammation, and infections. Numerous studies have shown that diosgenin has potential therapeutic value for lipid metabolism diseases via various pathways and mechanisms, such as controlling lipid synthesis, absorption, and inhibition of oxidative stress. These mechanisms and pathways have provided ideas for researchers to develop related drugs. In this review, we focus on data from animal and clinical studies, summarizing the toxicity of diosgenin, its pharmacological mechanism, recent research advances, and the related mechanisms of diosgenin as a drug for the treatment of lipid metabolism, especially in obesity, hyperlipidemia, nonalcoholic fatty liver disease, atherosclerosis, and diabetes. This systematic review will briefly describe the advantages of diosgenin as a potential therapeutic drug and seek to enhance our understanding of the pharmacological mechanism, recipe-construction, and the development of novel therapeutics against lipid metabolism diseases.
Full Text
Topics from this Paper
Controlling Lipid Synthesis
Nonalcoholic Fatty Liver Disease
Lipid Metabolism Diseases
Potential Therapeutic Drug
Steroidal Saponin
+ Show 5 more
Create a personalized feed of these topics
Get StartedSimilar Papers
Journal of Lipids
Jan 1, 2012
Frontiers in Cell and Developmental Biology
Sep 20, 2021
Visceral Medicine
Apr 13, 2021
Herald of Pancreatic Club
Dec 23, 2020
Jan 1, 2016
World Journal of Hepatology
Jul 27, 2022
Therapeutic Advances in Endocrinology and Metabolism
Jan 1, 2020
Experimental & Molecular Medicine
Nov 30, 2021
Metabolism: clinical and experimental
Jun 1, 2022
Mar 20, 2014
Food research international (Ottawa, Ont.)
Jan 1, 2021
Diabetes, metabolic syndrome and obesity : targets and therapy
Jan 1, 2021
BioMed Research International
Dec 14, 2020
Social Science Research Network
Nov 25, 2019
Digestive Diseases and Sciences
Jan 18, 2013